<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04828421</url>
  </required_header>
  <id_info>
    <org_study_id>UALBIO2020/001</org_study_id>
    <nct_id>NCT04828421</nct_id>
  </id_info>
  <brief_title>The Effect of Probiotic Supplementation on Cognitive and Emotional Functions in Healthy Elderly Subjects</brief_title>
  <official_title>The Effect of Probiotic Supplementation on Cognitive and Emotional Functions in Healthy Elderly Subjects: a Randomized, Double-blind, Cross-over and Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad de Almeria</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad de Almeria</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the cognitive and emotional effects of probiotics in healthy elderly&#xD;
      patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Gut microbiota (GM) has focused as an important target for emotional and cognitive diseases,&#xD;
      moreover in a population that show an altered GM such as elderly population as age-related&#xD;
      changes. Several studies have shown that ageing alter GM, both in diversity and integrity.&#xD;
&#xD;
      Probiotics have demonstrated that correct or prevent age-related dysbiosis, in order to&#xD;
      reduce or prevent intestinal permeability and associated inflammation, inhibit the generation&#xD;
      of harmful and/or toxic metabolites, as well as promote the production of beneficial&#xD;
      bacterial components.&#xD;
&#xD;
      The aim of this study is to assess the effectiveness of a multiprobiotic formulation as a&#xD;
      therapeutic strategy to attenuate the emotional and cognitive decline associated with ageing&#xD;
      in healthy adults over 55 years of age. The hypothesis is that administration of a&#xD;
      multi-species probiotic for 10 weeks will slow and/or ameliorate the decline in emotional and&#xD;
      cognitive function inherent to senescence.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 17, 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline Anxiety at 10 weeks</measure>
    <time_frame>Before and after treatment (10 weeks)</time_frame>
    <description>The State-Trait Anxiety Inventory. Score range: 20-80</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Depression at 10 weeks</measure>
    <time_frame>Before and after treatment (10 weeks)</time_frame>
    <description>The Beck Depression Inventory. Score range: 0-63.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline General Cognitive Status at 10 weeks</measure>
    <time_frame>Before and after treatment (10 weeks)</time_frame>
    <description>Mini-Mental State Examination. Score range: 0-35</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Working Memory at 10 weeks</measure>
    <time_frame>Before and after treatment (10 weeks)</time_frame>
    <description>Digits task, Corsi task</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Planning Ability at 10 weeks</measure>
    <time_frame>Before and after treatment (10 weeks)</time_frame>
    <description>Tower of London test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Problem-solving ability at 10 weeks</measure>
    <time_frame>Before and after treatment (10 weeks)</time_frame>
    <description>Wisconsin Card Sorting test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Selective attention, cognitive flexibility and response inhibition at 10 weeks</measure>
    <time_frame>Before and after treatment (10 weeks)</time_frame>
    <description>Stroop task</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Visual Attention at 10 weeks</measure>
    <time_frame>Before and after treatment (10 weeks)</time_frame>
    <description>Trail Making Test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Motor impulsivity or inhibitory response at 10 weeks</measure>
    <time_frame>Before and after treatment (10 weeks)</time_frame>
    <description>Go/No-Go task</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Choice impulsivity or impulsive decision-making at 10 weeks</measure>
    <time_frame>Before and after treatment (10 weeks)</time_frame>
    <description>Iowa Gambling Task</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Food Habits at 10 weeks</measure>
    <time_frame>Before and after treatment (10 weeks)</time_frame>
    <description>&quot;24-hour recall&quot; questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Alcohol Use at 10 weeks</measure>
    <time_frame>Before and after treatment (10 weeks)</time_frame>
    <description>The Alcohol Use Disorders Identification Test. Score range: 0-40</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Body Composition at 10 weeks</measure>
    <time_frame>Before and after treatment (10 weeks)</time_frame>
    <description>Fat mass. Body fat mass. Fat-free mass. Total body water.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Physical Activity at 10 weeks</measure>
    <time_frame>Before and after treatment (10 weeks)</time_frame>
    <description>International Physical Activity Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Stool Consistency at 10 weeks</measure>
    <time_frame>Before and after treatment (10 weeks)</time_frame>
    <description>The Bristol Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Sleep Quality at 10 weeks</measure>
    <time_frame>Before and after treatment (10 weeks)</time_frame>
    <description>The Pittsburgh Sleep Quality Index Questionnaire. Score range: 0-21</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Perceived Stress at 10 weeks</measure>
    <time_frame>Before and after treatment (10 weeks)</time_frame>
    <description>Perceived Stress Questionnaire. Score range: 0-1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Gastrointestinal Symptom at 10 weeks</measure>
    <time_frame>Before and after treatment (10 weeks)</time_frame>
    <description>Gastrointestinal Symptom Rating Scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Probiotic group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be treated with a daily capsule of a multi-species probiotic (3.3 billion Lactobacillus rhamnosus and Bifidobacterium lactis) during 10 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will receive a harmless substance (potato starch) during 10 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactobacillus rhamnosus and Bifidobacterium lactis</intervention_name>
    <description>Probiotics</description>
    <arm_group_label>Probiotic group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  be aged 55 years or over,&#xD;
&#xD;
          -  voluntarily agree to participate in the study in accordance with the Helsinki&#xD;
             declaration,&#xD;
&#xD;
          -  not be participating in another study that could interfere with the results.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  suffer from any serious mental illness other than depression and anxiety,&#xD;
&#xD;
          -  score below 10 on the Mini-Mental State Examination (MMSE) (severe cognitive&#xD;
             impairment)&#xD;
&#xD;
          -  be using medications that affect cognition,&#xD;
&#xD;
          -  taking anti-inflammatory drugs, antipsychotics, antibiotics and/or anxiolytics,&#xD;
&#xD;
          -  have a serious illness (e.g. cancer, Parkinson's or Alzheimer's).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>56 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>PABLO R LOPEZ</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad de Almeria</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universidad de Almeria</name>
      <address>
        <city>Almería</city>
        <state>Almeria</state>
        <zip>04120</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universidad de Almeria</name>
      <address>
        <city>La Cañada de San Urbano</city>
        <state>Almeria</state>
        <zip>04120</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pablo Roman</name>
      <address>
        <city>Almeria</city>
        <zip>04120</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 29, 2021</study_first_submitted>
  <study_first_submitted_qc>March 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2021</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad de Almeria</investigator_affiliation>
    <investigator_full_name>Pablo Román López</investigator_full_name>
    <investigator_title>Principal Investigator, Vicedean of Nursing</investigator_title>
  </responsible_party>
  <keyword>Probiotics</keyword>
  <keyword>Cognitive</keyword>
  <keyword>Emotional</keyword>
  <keyword>Aging</keyword>
  <keyword>Elderly</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

